Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Research from Boehringer Ingelheim GmbH has provided new information about vaccines
September 10th, 2008
"The effects of a single-dose recombinant Porcine circovirus type 2 (PCV2) open reading frame 2 (ORF2) subunit vaccine were studied in a post-weaning multisystemic wasting syndrome (PMWS)-affected pig herd. A total of 1519 3-week-old piglets were allocated randomly into two treatmentgroups and eithervaccinated against PCV2 or treated with a placebo," scientists in Ingelheim, Germany report. "Study animals were followed from the time ofvaccination until the end of finishing. Onset of PCV2 viraernia and clinical signs of PMWS (wasting, cough, dyspnoea, pallor and lethargy) were observed when animals were approximately 9-10 weeks old. Compared to placebo-treated animals,...
Source: Vaccine Weekly (2008-09-10)
|
